ラテラルフローアッセイ市場：製品（キット、リーダー）、用途（臨床検査、動物診断、食品安全・環境検査）、手法（サンドイッチ、マルチプレックス検出アッセイ）、エンドユーザー（病院、ホームケア）別 - 2027年までの世界予測

Lateral Flow Assays Market by Product (Kits, Readers), Application (Clinical Testing, Veterinary Diagnostics, Food Safety & Environmental Testing), Technique (Sandwich, Multiplex Detection Assay), End User (Hospitals, Home care) - Global Forecast to 2027

ラテラルフローアッセイの世界市場は、2022年の205億米ドルから2027年には226億米ドルに達すると予測され、予測期間中のCAGRは2.0%になると予測されます。ラテラルフローアッセイ市場の成長は、多くの国々におけ... もっと見る

出版社	出版年月	電子版価格	ページ数	図表数	言語
MarketsandMarkets マーケッツアンドマーケッツ	2023年2月14日	US$4,950 シングルユーザライセンスライセンス・価格情報注文方法はこちら	375	425	英語

日本語のページは自動翻訳を利用し作成しています。

サマリー

ラテラルフローアッセイの世界市場は、2022年の205億米ドルから2027年には226億米ドルに達すると予測され、予測期間中のCAGRは2.0%になると予測されます。ラテラルフローアッセイ市場の成長は、多くの国々における感染症の高い有病率、ポイントオブケア検査に対する需要の高まり、家庭用ラテラルフローアッセイ機器の使用の増加によるものですが、医師や患者が既存の診断手順を変更することに消極的で、ラテラルフローアッセイの精度が低いことが市場の抑制となっています。

"2021年、ラテラルフローアッセイ市場で尿検体が第3位のシェアを占める"
サンプルタイプに基づき、臨床検査用ラテラルフローアッセイ市場は、血液、尿、唾液、その他のサンプルに区分されます。2021年の市場シェアは、尿サンプルが第3位を占めています。妊娠、不妊検査、乱用薬物検査などのラテラルフローテストにおいて、尿サンプルの使用が増加していることが背景にある。
"製薬・バイオテクノロジー企業セグメントが予測期間中に最も速い成長を遂げると予想される"
ラテラルフローアッセイ市場は、エンドユーザーに基づき、病院・クリニック、診断ラボ、在宅医療、製薬・バイオテクノロジー企業、その他のエンドユーザーに分類されます。予測期間中、製薬・バイオテクノロジー企業セグメントが最も速い成長を遂げると予想されています。この成長は、製薬・バイオテクノロジー企業において、サンプルの定量検出のためのラテラルフローアッセイリーダーやキット・試薬の採用が増加していることに起因しています。

"2021年、ラテラルフローアッセイ市場でアジア太平洋地域が2位のシェアを占める"
北米、欧州、アジア太平洋、中南米、中東・アフリカの順です。2021年、ラテラルフローアッセイ市場では、アジア太平洋が2番目に大きなシェアを占め、次いでヨーロッパ、ラテンアメリカ、中東＆アフリカの順となりました。しかし、北米はラテラルフローアッセイ市場の主要地域となっています。高成長市場であるアジア太平洋地域では、多くのメーカーが製造拠点を拡大しており、特に中国とインドでは、低コストで製造できる利点と熟練労働者の確保が可能です。また、これらの国々は、世界中で最も収益性の高い製造・研究開発拠点とみなされています。この地域の市場成長を妨げる主な要因は、識字率の低さ、償還金の不足、遠隔地に関する課題、医師が既存の慣習を変えることに消極的であるため、近接患者用検査製品の利点に関する認識が不足していることです。

本レポートで参照したラテラルフローアッセイ市場の主要参入企業（サプライサイド）の内訳は以下の通りです：
- 企業タイプ別：Tier1-35%、Tier2-20%、Tier3-45%。
- 役職別Cレベル-45％、ディレクターレベル-25％、その他-30
- 地域別北米36％、欧州26％、アジア太平洋21％、中南米10％、中近東・アフリカ7％。
ラテラルフローアッセイ市場の主なプレイヤーとしては、Abbott Laboratories（米国）、F. Hoffman-La Roche AG（スイス）、Danaher Corporation（米国）、Siemens AG（ドイツ）、BD（米国）、bioMérieux SA（フランス）、Thermo Fisher Scientific, Inc（米国）、PerkinElmer Inc（米国）、Hologic Inc（米国）、QIAGEN N.V. （オランダ）、Quidel Corporation （米国）および Merck KGaA（ドイツ）があります。

調査対象範囲
この調査レポートは、様々なセグメントにわたるラテラルフローアッセイ市場を対象としています。製品タイプ別、技術別アプリケーション別、サンプルタイプ別、エンドユーザー別、地域別の異なるセグメントにおける市場規模およびこの市場の成長可能性を推定することを目的としています。また、本調査には、市場の主要企業の詳細な競合分析が含まれており、企業プロフィール、製品や事業の提供、最近の開発、主要な市場戦略に関する重要な見解も併せて掲載しています。
レポートを購入する主な利点
本レポートは、本市場のマーケットリーダー/新規参入者に役立ち、ラテラルフローアッセイ市場およびそのセグメントの最も近い近似値に関する情報を提供します。本レポートは、関係者が競争環境を理解し、ビジネスをより良く位置づけるための洞察を得て、適切な市場参入戦略を計画するのに役立ちます。また、市場の脈動を理解し、主要な市場促進要因、阻害要因、機会、課題に関する情報を得る上で、関係者の助けとなることでしょう。

ページTOPに戻る

1 INTRODUCTION 32
1.1 STUDY OBJECTIVES 32
1.2 MARKET DEFINITION 32
1.2.1 INCLUSIONS AND EXCLUSIONS 33
1.3 MARKET SCOPE 34
1.3.1 MARKETS COVERED 34
FIGURE 1 LATERAL FLOW ASSAYS MARKET SEGMENTATION 34
FIGURE 2 REGIONAL SCOPE 35
1.3.2 YEARS CONSIDERED 35
1.4 CURRENCY CONSIDERED 35
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 36
1.5 STAKEHOLDERS 36
1.6 SUMMARY OF CHANGES 36
1.6.1 RECESSION IMPACT 37
2 RESEARCH METHODOLOGY 38
2.1 RESEARCH APPROACH 38
FIGURE 3 RESEARCH DESIGN 38
2.1.1 SECONDARY DATA 38
2.1.1.1 Key data from secondary sources 39
2.1.2 PRIMARY DATA 40
2.1.2.1 Primary sources 40
2.1.2.2 Key data from primary sources 41
2.1.2.3 Breakdown of primaries 41
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 41
2.2 MARKET SIZE ESTIMATION 42
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2021) 43
FIGURE 6 SUPPLY-SIDE ANALYSIS: LATERAL FLOW ASSAYS MARKET (2021) 43
FIGURE 7 APPROACH 3: DEMAND-SIDE APPROACH, BASED ON MALARIA LATERAL FLOW TESTING MARKET SIZE (2021) 44
FIGURE 8 TOP-DOWN APPROACH 44
FIGURE 9 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2022–2027): IMPACT ON MARKET GROWTH AND CAGR 46
FIGURE 10 CAGR PROJECTIONS 46
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 47
FIGURE 11 DATA TRIANGULATION METHODOLOGY 48
2.4 KEY INDUSTRY INSIGHTS 49
2.5 LIMITATIONS 49
2.5.1 METHODOLOGY-RELATED LIMITATIONS 49
2.6 RISK ASSESSMENT 50
2.7 STUDY ASSUMPTIONS 50
2.8 RECESSION IMPACT 51
3 EXECUTIVE SUMMARY 52
FIGURE 12 LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION) 52
FIGURE 13 LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2022 VS. 2027 (USD MILLION) 53
FIGURE 14 LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION) 53
FIGURE 15 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2022 VS. 2027 (USD MILLION) 54
FIGURE 16 LATERAL FLOW ASSAYS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION) 55
FIGURE 17 GEOGRAPHIC SNAPSHOT OF LATERAL FLOW ASSAYS MARKET 56
4 PREMIUM INSIGHTS 57
4.1 LATERAL FLOW ASSAYS MARKET OVERVIEW 57
FIGURE 18 HIGH PREVALENCE OF INFECTIOUS DISEASES TO DRIVE MARKET 57
4.2 REGIONAL MIX: LATERAL FLOW ASSAYS MARKET 57
FIGURE 19 ASIA PACIFIC TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 57
4.3 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY APPLICATION AND COUNTRY (2021) 58
FIGURE 20 CLINICAL TESTING SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2021 58
4.4 LATERAL FLOW ASSAYS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 59
FIGURE 21 CHINA TO REGISTER HIGHEST GROWTH IN FORECAST PERIOD 59
4.5 LATERAL FLOW ASSAYS MARKET: DEVELOPING VS. DEVELOPED COUNTRIES 60
FIGURE 22 DEVELOPING COUNTRIES TO OFFER HIGH GROWTH OPPORTUNITIES IN FORECAST PERIOD 60
5 MARKET OVERVIEW 61
5.1 INTRODUCTION 61
5.2 MARKET DYNAMICS 61
FIGURE 23 LATERAL FLOW ASSAYS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 61
5.2.1 DRIVERS 62
5.2.1.1 High prevalence of infectious diseases 62
TABLE 2 PREVALENCE OF HIV WORLDWIDE (2017 VS. 2021) 62
5.2.1.2 Rapidly increasing geriatric population 63
FIGURE 24 GERIATRIC POPULATION, BY REGION, 2020 VS. 2050 (MILLION) 63
FIGURE 25 GERIATRIC POPULATION, BY REGION, 2022 VS. 2030 VS. 2050 (% OF TOTAL POPULATION) 64
5.2.1.3 Growing use of home-based lateral flow assay devices 64
5.2.1.4 Growing demand for point-of-care testing 65
5.2.1.5 Need for rapid diagnostic testing for COVID-19 65
5.2.2 RESTRAINTS 66
5.2.2.1 Inconsistent results of lateral flow assay tests 66
5.2.3 OPPORTUNITIES 66
5.2.3.1 Evolving applications of lateral flow assays 66
TABLE 3 LIST OF COMMERCIALLY AVAILABLE SALIVA LFA PRODUCTS 67
5.2.3.2 Rising demand for lateral flow assays in food & beverage industry 67
5.2.3.3 Omicron offers growth opportunities for players in lateral flow assays market 68
TABLE 4 EPIDEMIOLOGICAL UPDATE ON OMICRON VARIANT 68
TABLE 5 EXAMPLES OF LATERAL FLOW ASSAY KITS AVAILABLE FOR DETECTION OF OMICRON 68
5.2.4 CHALLENGES 69
5.2.4.1 Limited reimbursements for lateral flow assay products 69
5.2.4.2 Difficulties in procuring quality raw materials for development of lateral flow assay tests 70
5.3 COVID-19 IMPACT ASSESSMENT ON ECONOMIC SCENARIO 70
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 70
FIGURE 26 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 71
5.5 AVERAGE SELLING PRICE TREND 71
5.5.1 AVERAGE SELLING PRICES OF KEY PLAYERS, BY APPLICATION 71
TABLE 6 AVERAGE SELLING PRICE OF LATERAL FLOW ASSAYS (KITS AND REAGENTS) 71
5.5.2 AVERAGE SELLING PRICE TRENDS 72
TABLE 7 AVERAGE SELLING PRICE OF LATERAL FLOW ANALYZERS, BY REGION, 2020 VS. 2021 72
5.6 ECOSYSTEM MARKET MAP 72
FIGURE 27 LATERAL FLOW ASSAYS MARKET: ECOSYSTEM ANALYSIS (2021) 73
5.7 PATENT ANALYSIS 74
5.7.1 PATENT PUBLICATION TRENDS FOR LATERAL FLOW ASSAYS 74
FIGURE 28 GLOBAL PATENT PUBLICATION TRENDS IN LATERAL FLOW ASSAYS MARKET, 2016–2022 74
5.7.2 TOP APPLICANTS (COMPANIES) OF LATERAL FLOW ASSAY PATENTS 75
FIGURE 29 TOP COMPANIES THAT APPLIED FOR LATERAL FLOW ASSAY PATENTS, 2016–2022 75
5.7.3 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN LATERAL FLOW ASSAYS MARKET 75
FIGURE 30 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR LATERAL FLOW ASSAY PATENTS, 2016–2022 75
5.8 VALUE CHAIN ANALYSIS 76
FIGURE 31 LATERAL FLOW ASSAYS MARKET: VALUE CHAIN ANALYSIS (2021) 76
5.9 TECHNOLOGY ANALYSIS 76
5.9.1 KEY TECHNOLOGY: LATERAL FLOW ASSAYS 76
5.9.2 ADJACENT TECHNOLOGY: ENZYME-LINKED IMMUNOSORBENT ASSAYS 77
5.10 CASE STUDY ANALYSIS 77
5.11 REGULATORY ANALYSIS 78
5.11.1 REGULATORY LANDSCAPE 78
5.11.1.1 North America 78
5.11.1.2 Europe 78
5.11.1.3 Asia 79
5.11.1.3.1 India 79
5.11.1.3.2 China 79
5.11.1.3.3 Japan 79
5.11.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 80
TABLE 8 REGULATORY STANDARDS/APPROVALS REQUIRED FOR LATERAL FLOW IMMUNOASSAY BY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 80
5.12 PORTER’S FIVE FORCES ANALYSIS 80
TABLE 9 LATERAL FLOW ASSAYS MARKET: PORTER’S FIVE FORCES ANALYSIS 80
5.12.1 THREAT OF NEW ENTRANTS 81
5.12.2 THREAT OF SUBSTITUTES 81
5.12.3 BARGAINING POWER OF SUPPLIERS 82
5.12.4 BARGAINING POWER OF BUYERS 82
5.12.5 INTENSITY OF COMPETITIVE RIVALRY 82
5.13 ADJACENT MARKET ANALYSIS 82
5.14 KEY CONFERENCES AND EVENTS DURING 2023–2024 83
TABLE 10 LATERAL FLOW ASSAYS MARKET: DETAILED LIST OF CONFERENCES & EVENTS 83
5.15 KEY STAKEHOLDERS AND BUYING CRITERIA 84
5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS 84
FIGURE 32 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS 84
TABLE 11 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS 84
5.15.2 BUYING CRITERIA 84
FIGURE 33 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS 84
5.16 TRADE ANALYSIS 85
5.17 INDUSTRY TRENDS 85
5.17.1 DETECTION OF HIV WITH LATERAL FLOW ASSAYS 85
TABLE 12 US: HIV PREVALENCE RATE, 2016–2020 85
5.17.2 INCREASING ADOPTION OF QUANTITATIVE LATERAL FLOW ASSAYS DUE TO AVAILABILITY OF LFA READERS 86
5.18 IMPACT OF INFLATION AND RECESSION ON LATERAL FLOW ASSAYS MARKET 86

6 LATERAL FLOW ASSAYS MARKET, BY PRODUCT 88
6.1 INTRODUCTION 89
TABLE 13 LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 89
6.2 KITS AND REAGENTS 89
6.2.1 INCREASING DEMAND FOR POC TESTING TO DRIVE MARKET 89
TABLE 14 LATERAL FLOW KITS AND REAGENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 90
6.3 LATERAL FLOW READERS 90
TABLE 15 EXAMPLES OF LATERAL FLOW READERS AVAILABLE IN MARKET 91
TABLE 16 LATERAL FLOW ASSAY KITS AND REAGENTS WITH AND WITHOUT ANALYZERS 92
TABLE 17 LATERAL FLOW READERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 93
TABLE 18 LATERAL FLOW READERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 93
TABLE 19 LATERAL FLOW READERS MARKET, BY END USER, 2020–2027 (USD MILLION) 93
TABLE 20 LATERAL FLOW READERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 94
6.3.1 DIGITAL/HANDHELD READERS 94
6.3.1.1 Technological advancements and high accuracy—major factors driving market 94
TABLE 21 DIGITAL/HANDHELD LATERAL FLOW READERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 95
TABLE 22 DIGITAL/HANDHELD LATERAL FLOW READERS MARKET, BY REGION, 2020–2027 (THOUSAND UNITS) 96
6.3.2 BENCHTOP READERS 96
6.3.2.1 Lower diagnosis cost per patient to drive adoption 96
TABLE 23 BENCHTOP LATERAL FLOW READERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 97
TABLE 24 BENCHTOP LATERAL FLOW READERS MARKET, BY REGION, 2020–2027 (THOUSAND UNITS) 97
6.4 INSIGHTS ON DISPOSABLE AND REUSABLE LATERAL FLOW READERS 98
6.5 LATERAL FLOW READERS MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY TYPE 98
6.5.1 PRODUCT PORTFOLIO ANALYSIS OF LATERAL FLOW READERS FOR CLINICAL DIAGNOSTIC APPLICATIONS 98
TABLE 25 PRODUCT PORTFOLIO ANALYSIS OF LATERAL FLOW READERS FOR CLINICAL DIAGNOSTIC APPLICATIONS 98
FIGURE 34 PRODUCT PORTFOLIO ANALYSIS OF LATERAL FLOW READERS FOR CLINICAL DIAGNOSTICS (2021) 100
7 LATERAL FLOW ASSAYS MARKET, BY APPLICATION 101
7.1 INTRODUCTION 102
TABLE 26 LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 102
7.2 CLINICAL TESTING 102
TABLE 27 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2020–2027 (USD MILLION) 103
TABLE 28 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 104
7.2.1 INFECTIOUS DISEASE TESTING 104
TABLE 29 LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020–2027 (USD MILLION) 105
TABLE 30 LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 106
7.2.1.1 Mosquito-borne diseases 106
7.2.1.1.1 Increasing incidence of dengue to support market growth 106
TABLE 31 DENGUE TESTING PRODUCTS AVAILABLE IN MARKET 107
TABLE 32 LATERAL FLOW ASSAYS MARKET FOR MOSQUITO-BORNE DISEASES, BY COUNTRY, 2020–2027 (USD MILLION) 108
7.2.1.2 COVID-19 109
7.2.1.2.1 COVID-19 pandemic resulted in adoption of rapid lateral flow tests 109
TABLE 33 LATERAL FLOW ASSAY TESTS FOR COVID-19 (ANTIGEN AND ANTIBODY) 109
TABLE 34 LATERAL FLOW ASSAYS MARKET FOR COVID-19, BY COUNTRY, 2020–2027 (USD MILLION) 110
7.2.1.3 Influenza 111
7.2.1.3.1 Growing prevalence of influenza to support market growth 111
TABLE 35 LATERAL FLOW ASSAYS MARKET FOR INFLUENZA, BY COUNTRY, 2020–2027 (USD MILLION) 112
7.2.1.4 Sexually transmitted infections 112
TABLE 36 LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020–2027 (USD MILLION) 113
TABLE 37 LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2020–2027 (USD MILLION) 114
7.2.1.4.1 HIV 114
7.2.1.4.1.1 Growing awareness of HIV POC testing to drive market 114
TABLE 38 LATERAL FLOW ASSAYS MARKET FOR HIV, BY COUNTRY, 2020–2027 (USD MILLION) 116
7.2.1.4.2 HPV 116
7.2.1.4.2.1 Rising adoption of HPV testing to drive market during forecast period 116
TABLE 39 LATERAL FLOW ASSAYS MARKET FOR HPV, BY COUNTRY, 2020–2027 (USD MILLION) 117
7.2.1.4.3 Chlamydia 117
7.2.1.4.3.1 Growing incidence of chlamydia and rising awareness among patients to drive market 117
TABLE 40 LATERAL FLOW ASSAYS MARKET FOR CHLAMYDIA, BY COUNTRY, 2020–2027 (USD MILLION) 118
7.2.1.4.4 Gonorrhea 118
7.2.1.4.4.1 Rising incidence of gonorrhea and increased funding for R&D to support market growth 118
TABLE 41 LATERAL FLOW ASSAYS MARKET FOR GONORRHEA, BY COUNTRY, 2020–2027 (USD MILLION) 119
7.2.1.4.5 Syphilis 120
7.2.1.4.5.1 Growing adoption of novel technologies to support market growth 120
TABLE 42 LATERAL FLOW ASSAYS MARKET FOR SYPHILIS, BY COUNTRY, 2020–2027 (USD MILLION) 121
7.2.1.4.6 Other sexually transmitted infections 121
TABLE 43 LATERAL FLOW ASSAYS MARKET FOR OTHER SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2020–2027 (USD MILLION) 122
7.2.1.5 Hepatitis 122
7.2.1.5.1 Nucleic acid hybridization-based lateral flow assays hold great potential in hepatitis testing market 122
TABLE 44 LATERAL FLOW ASSAYS MARKET FOR HEPATITIS, BY COUNTRY, 2020–2027 (USD MILLION) 123
7.2.1.6 Tuberculosis 123
7.2.1.6.1 Rising prevalence and growing focus on early diagnosis and treatment to drive market 123
TABLE 45 LATERAL FLOW ASSAYS MARKET FOR TUBERCULOSIS, BY COUNTRY, 2020–2027 (USD MILLION) 124
7.2.1.7 Other infectious diseases 124
TABLE 46 LATERAL FLOW ASSAYS MARKET FOR OTHER INFECTIOUS DISEASES, BY COUNTRY, 2020–2027 (USD MILLION) 125
7.2.2 CARDIAC MARKER TESTING 126
TABLE 47 LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020–2027 (USD MILLION) 126
TABLE 48 LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 127
7.2.2.1 Troponin I and T 127
7.2.2.1.1 Introduction of high-sensitivity troponin assays to drive market 127
TABLE 49 LATERAL FLOW ASSAYS MARKET FOR TROPONIN I AND T TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 128
7.2.2.2 CK-MB 128
7.2.2.2.1 Growing applications of lateral flow tests in acute myocardial injuries to drive market 128
TABLE 50 LATERAL FLOW ASSAYS MARKET FOR CK-MB TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 129
7.2.2.3 BNP and NT-proBNP 129
7.2.2.3.1 Increasing demand for cardiac biomarker tests to detect heart stress and damage to propel adoption 129
TABLE 51 LATERAL FLOW ASSAYS MARKET FOR BNP AND NT-PROBNP TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 130
7.2.2.4 Myoglobin 130
7.2.2.4.1 Availability of new high-sensitivity cardiac troponin assays to restrict market growth 130
TABLE 52 LATERAL FLOW ASSAYS MARKET FOR MYOGLOBIN TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 131
7.2.2.5 D-dimer 131
7.2.2.5.1 Rising incidence of cardiovascular diseases to drive market for D-dimer tests 131
TABLE 53 LATERAL FLOW ASSAYS MARKET FOR D-DIMER TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 132
7.2.2.6 Other cardiac markers 132
TABLE 54 LATERAL FLOW ASSAYS MARKET FOR OTHER CARDIAC MARKER TESTS, BY COUNTRY, 2020–2027 (USD MILLION) 133
7.2.3 PREGNANCY AND FERTILITY TESTING 133
TABLE 55 LATERAL FLOW ASSAYS MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020–2027 (USD MILLION) 134
TABLE 56 LATERAL FLOW ASSAYS MARKET FOR PREGNANCY AND FERTILITY TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 135
7.2.3.1 Pregnancy testing 135
7.2.3.1.1 Most common application area for lateral flow assays 135
TABLE 57 LATERAL FLOW ASSAYS MARKET FOR PREGNANCY TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 136
7.2.3.2 Fertility testing 136
7.2.3.2.1 Rising infertility rates to drive demand for POC fertility testing kits 136
TABLE 58 LATERAL FLOW ASSAYS MARKET FOR FERTILITY TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 137
7.2.4 CHOLESTEROL/LIPID TESTING 137
7.2.4.1 Growing prevalence of obesity and CVD to drive market 137
TABLE 59 LATERAL FLOW ASSAYS MARKET FOR CHOLESTEROL/LIPID TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 138
7.2.5 DRUGS-OF-ABUSE TESTING 138
7.2.5.1 Technological advancements and growing focus on workplace drug testing to drive market 138
TABLE 60 LATERAL FLOW ASSAYS MARKET FOR DRUGS-OF-ABUSE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 139
7.2.6 OTHER CLINICAL TESTS 139
TABLE 61 LATERAL FLOW ASSAYS MARKET FOR OTHER CLINICAL TESTS, BY COUNTRY, 2020–2027 (USD MILLION) 140
7.3 VETERINARY DIAGNOSTICS 140
7.3.1 INFECTIOUS DISEASE OUTBREAKS, PARTICULARLY IN LARGE LIVESTOCK ANIMALS, TO DRIVE MARKET 140
TABLE 62 LATERAL FLOW ASSAYS MARKET FOR VETERINARY DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION) 141
7.4 FOOD SAFETY AND ENVIRONMENTAL TESTING 142
7.4.1 HIGH SENSITIVITY AND EASE OF USE SUPPORTING MARKET GROWTH 142
TABLE 63 LATERAL FLOW ASSAYS MARKET FOR FOOD SAFETY AND ENVIRONMENTAL TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 143
7.5 DRUG DEVELOPMENT AND QUALITY TESTING 143
7.5.1 INCREASING FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE TO DRIVE MARKET 143
TABLE 64 LATERAL FLOW ASSAYS MARKET FOR DRUG DEVELOPMENT AND QUALITY TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 144

8 LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE 145
8.1 INTRODUCTION 146
TABLE 65 LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 146
TABLE 66 LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 147
8.2 SANDWICH ASSAYS 147
8.2.1 WIDE APPLICATIONS IN CLINICAL TESTING TO SUPPORT MARKET GROWTH 147
TABLE 67 LATERAL FLOW SANDWICH ASSAYS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 148
8.3 COMPETITIVE ASSAYS 149
8.3.1 REDUCED SELECTIVITY AND SENSITIVITY IN RELATION TO SANDWICH ASSAYS TO HAMPER GROWTH 149
TABLE 68 LATERAL FLOW COMPETITIVE ASSAYS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 150
8.4 MULTIPLEX DETECTION ASSAYS 150
8.4.1 INCREASING ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO DRIVE MARKET 150
TABLE 69 LATERAL FLOW MULTIPLEX DETECTION ASSAYS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 151
9 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE 152
9.1 INTRODUCTION 153
TABLE 70 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020–2027 (USD MILLION) 153
9.2 BLOOD SAMPLES 153
9.2.1 INCREASING USE OF BLOOD SAMPLES IN INFECTIOUS DISEASE TESTING TO DRIVE MARKET 153
TABLE 71 LATERAL FLOW ASSAYS MARKET FOR BLOOD SAMPLES, BY COUNTRY, 2020–2027 (USD MILLION) 154
9.3 URINE SAMPLES 154
9.3.1 GROWING USE OF URINE SAMPLES IN PREGNANCY AND DRUGS-OF-ABUSE TESTING TO DRIVE MARKET 154
TABLE 72 LATERAL FLOW ASSAYS MARKET FOR URINE SAMPLES, BY COUNTRY, 2020–2027 (USD MILLION) 155
9.4 SALIVA SAMPLES 155
9.4.1 EASY AND LOW-COST COLLECTION, TRANSPORT, AND ANALYSIS OF SALIVA SAMPLES TO SUPPORT ADOPTION 155
TABLE 73 LATERAL FLOW ASSAYS MARKET FOR SALIVA SAMPLES, BY COUNTRY, 2020–2027 (USD MILLION) 156
9.5 OTHER SAMPLES 157
TABLE 74 LATERAL FLOW ASSAYS MARKET FOR OTHER SAMPLES, BY COUNTRY, 2020–2027 (USD MILLION) 157

10 LATERAL FLOW ASSAYS MARKET, BY END USER 158
10.1 INTRODUCTION 159
TABLE 75 LATERAL FLOW ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION) 159
10.2 HOSPITALS AND CLINICS 159
10.2.1 INCREASING USE OF POC TESTS TO DRIVE MARKET 159
TABLE 76 LATERAL FLOW ASSAYS MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2020–2027 (USD MILLION) 160
10.3 HOME CARE SETTINGS 160
10.3.1 GROWING ACCEPTANCE OF REMOTE MONITORING TO PROPEL MARKET 160
TABLE 77 LATERAL FLOW ASSAYS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2020–2027 (USD MILLION) 161
10.4 DIAGNOSTIC LABORATORIES 162
10.4.1 HIGH PREFERENCE FOR LABORATORY TESTING TO TEST URINE AND BLOOD SAMPLES TO SUPPORT MARKET GROWTH 162
TABLE 78 LATERAL FLOW ASSAYS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2020–2027 (USD MILLION) 163
10.5 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 163
10.5.1 INCREASING FOCUS ON PRODUCT SAFETY TO DRIVE ADOPTION OF LATERAL FLOW ASSAYS 163
TABLE 79 LATERAL FLOW ASSAYS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 164
10.6 OTHER END USERS 164
TABLE 80 LATERAL FLOW ASSAYS MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION) 165
11 LATERAL FLOW ASSAYS MARKET, BY REGION 166
11.1 INTRODUCTION 167
FIGURE 35 CHINA TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD 167
TABLE 81 LATERAL FLOW ASSAYS MARKET, BY REGION, 2020–2027 (USD MILLION) 168
11.2 NORTH AMERICA 168
TABLE 82 NORTH AMERICA: MACROECONOMIC INDICATORS 169
FIGURE 36 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET SNAPSHOT 169
TABLE 83 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 170
TABLE 84 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 170
TABLE 85 NORTH AMERICA: LATERAL FLOW READERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 170
TABLE 86 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 171
TABLE 87 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 171
TABLE 88 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 89 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 90 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020–2027 (USD MILLION) 173
TABLE 91 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020–2027 (USD MILLION) 173
TABLE 92 NORTH AMERICA: LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 173
TABLE 93 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020–2027 (USD MILLION) 174
TABLE 94 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION) 174
11.2.1 US 174
11.2.1.1 Largest market for lateral flow assays 174
TABLE 95 US: MACROECONOMIC INDICATORS 175
TABLE 96 US: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 175
TABLE 97 US: LATERAL FLOW READERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 98 US: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 176
TABLE 99 US: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 100 US: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020–2027 (USD MILLION) 177
TABLE 101 US: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020–2027 (USD MILLION) 177
TABLE 102 US: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020–2027 (USD MILLION) 178
TABLE 103 US: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020–2027 (USD MILLION) 178
TABLE 104 US: LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 178
TABLE 105 US: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020–2027 (USD MILLION) 179
TABLE 106 US: LATERAL FLOW ASSAYS MARKET, BY END USER, 2020–2027 USD MILLION) 179
11.2.2 CANADA 179
11.2.2.1 Availability of research funding and implementation of favorable government initiatives to drive market 179
TABLE 107 CANADA: MACROECONOMIC INDICATORS 180
TABLE 108 CANADA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 180
TABLE 109 CANADA: LATERAL FLOW READERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 181
TABLE 110 CANADA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 181
TABLE 111 CANADA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 182
TABLE 112 CANADA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020–2027 (USD MILLION) 182
TABLE 113 CANADA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020–2027 (USD MILLION) 183
TABLE 114 CANADA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020–2027 (USD MILLION) 183
TABLE 115 CANADA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020–2027 (USD MILLION) 184
TABLE 116 CANADA: LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 184
TABLE 117 CANADA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020–2027 (USD MILLION) 184
TABLE 118 CANADA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2020–2027 USD MILLION) 185
11.2.3 RECESSION IMPACT 185
11.3 EUROPE 186
TABLE 119 EUROPE: LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 186
TABLE 120 EUROPE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 186
TABLE 121 EUROPE: LATERAL FLOW READERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 187
TABLE 122 EUROPE: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 187
TABLE 123 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 187
TABLE 124 EUROPE: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020–2027 (USD MILLION) 188
TABLE 125 EUROPE: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020–2027 (USD MILLION) 188
TABLE 126 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020–2027 (USD MILLION) 189
TABLE 127 EUROPE: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020–2027 (USD MILLION) 189
TABLE 128 EUROPE: LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 189
TABLE 129 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020–2027 (USD MILLION) 190
TABLE 130 EUROPE: LATERAL FLOW ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION) 190
11.3.1 GERMANY 190
11.3.1.1 Growing number of POC diagnostic centers to drive demand for lateral flow assays 190
TABLE 131 GERMANY: MACROECONOMIC INDICATORS 191
TABLE 132 GERMANY: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 191
TABLE 133 GERMANY: LATERAL FLOW READERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 191
TABLE 134 GERMANY: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 192
TABLE 135 GERMANY: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 192
TABLE 136 GERMANY: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020–2027 (USD MILLION) 193
TABLE 137 GERMANY: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020–2027 (USD MILLION) 193
TABLE 138 GERMANY: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020–2027 (USD MILLION) 194
TABLE 139 GERMANY: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020–2027 (USD MILLION) 194
TABLE 140 GERMANY: LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 194
TABLE 141 GERMANY: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020–2027 (USD MILLION) 195
TABLE 142 GERMANY: LATERAL FLOW ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION) 195
11.3.2 FRANCE 196
11.3.2.1 High prevalence of age-related chronic and infectious diseases to drive market 196
TABLE 143 FRANCE: MACROECONOMIC INDICATORS 196
TABLE 144 FRANCE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 196
TABLE 145 FRANCE: LATERAL FLOW READERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 197
TABLE 146 FRANCE: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 197
TABLE 147 FRANCE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 198
TABLE 148 FRANCE: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020–2027 (USD MILLION) 198
TABLE 149 FRANCE: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020–2027 (USD MILLION) 199
TABLE 150 FRANCE: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020–2027 (USD MILLION) 199
TABLE 151 FRANCE: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020–2027 (USD MILLION) 200
TABLE 152 FRANCE: LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 200
TABLE 153 FRANCE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020–2027 (USD MILLION) 200
TABLE 154 FRANCE: LATERAL FLOW ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION) 201
11.3.3 UK 201
11.3.3.1 Rising prevalence of obesity to propel market 201
TABLE 155 UK: MACROECONOMIC INDICATORS 202
TABLE 156 UK: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 202
TABLE 157 UK: LATERAL FLOW READERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 202
TABLE 158 UK: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 203
TABLE 159 UK: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 203
TABLE 160 UK: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020–2027 (USD MILLION) 204
TABLE 161 UK: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020–2027 (USD MILLION) 204
TABLE 162 UK: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020–2027 (USD MILLION) 205
TABLE 163 UK: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020–2027 (USD MILLION) 205
TABLE 164 UK: LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 205
TABLE 165 UK: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020–2027 (USD MILLION) 206
TABLE 166 UK: LATERAL FLOW ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION) 206
11.3.4 ITALY 206
11.3.4.1 Growing initiatives toward decentralization of medical services to support market growth 206
TABLE 167 ITALY: MACROECONOMIC INDICATORS 207
TABLE 168 ITALY: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 207
TABLE 169 ITALY: LATERAL FLOW READERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 207
TABLE 170 ITALY: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 208
TABLE 171 ITALY: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 208
TABLE 172 ITALY: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020–2027 (USD MILLION) 209
TABLE 173 ITALY: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020–2027 (USD MILLION) 209
TABLE 174 ITALY: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020–2027 (USD MILLION) 210
TABLE 175 ITALY: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020–2027 (USD MILLION) 210
TABLE 176 ITALY: LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 210
TABLE 177 ITALY: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020–2027 (USD MILLION) 211
TABLE 178 ITALY: LATERAL FLOW ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION) 211
11.3.5 SPAIN 211
11.3.5.1 Increasing focus of international organizations and domestic players on development of POC products to aid market growth 211
TABLE 179 SPAIN: MACROECONOMIC INDICATORS 212
TABLE 180 SPAIN: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 212
TABLE 181 SPAIN: LATERAL FLOW READERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 212
TABLE 182 SPAIN: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 213
TABLE 183 SPAIN: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 213
TABLE 184 SPAIN: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020–2027 (USD MILLION) 214
TABLE 185 SPAIN: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020–2027 (USD MILLION) 214
TABLE 186 SPAIN: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020–2027 (USD MILLION) 215
TABLE 187 SPAIN: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020–2027 (USD MILLION) 215
TABLE 188 SPAIN: LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 215
TABLE 189 SPAIN: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020–2027 (USD MILLION) 216
TABLE 190 SPAIN: LATERAL FLOW ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION) 216
11.3.6 REST OF EUROPE 216
TABLE 191 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 217
TABLE 192 REST OF EUROPE: LATERAL FLOW READERS MARKET, BY TYPE, 2020–2027 (USD MILLION) 217
TABLE 193 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 217
TABLE 194 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 218
TABLE 195 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020–2027 (USD MILLION) 218
TABLE 196 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020–2027 (USD MILLION) 219
TABLE 197 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020–2027 (USD MILLION) 219
TABLE 198 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020–2027 (USD MILLION) 220
TABLE 199 REST OF EUROPE: LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 220
TABLE 200 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020–2027 (USD MILLION) 220
TABLE 201 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION) 221
11.3.7 RECESSION IMPACT 221

ページTOPに戻る

Table of Contents

Summary

The global lateral flow assays market is projected to reach USD 22.6 billion by 2027 from USD 20.5 billion in 2022, at a CAGR of 2.0% during the forecast period. The growth of lateral flow assay market is due to the high prevalence of infectious diseases in many countries, growing demand for point-of-care testing, and rising use of home-based lateral flow assay devices whereas reluctance among doctors and patients to change existing diagnostic procedures and the low accuracy of lateral flow assays are restraining the market.

“Urine samples accounted for the third largest share of lateral flow assays market in 2021”
Based on sample type, the clinical testing lateral flow assays market is segmented into blood, urine, saliva, and other samples. Urine samples accounted for the third largest market share in 2021. The increasing use of urine samples in lateral flow tests for pregnancy, fertility testing, and drug of abuse testing.
“The Pharmaceutical & Biotechnology Companies segment is expected to witness the fastest growth during the forecast period”
Based on end users, the lateral flow assays market is segmented into hospitals & clinics, diagnostic laboratories, home care settings, pharmaceutical & biotechnology companies, and other end users. The pharmaceutical & biotechnology companies segment is expected to witness the fastest growth during the forecast period. This growth is owing to increasing adoption of lateral flow assay readers and kits & reagents for quantitative detection of sample in pharmaceutical & biotechnology companies.

“Asia-Pacific accounted for the second largest share of the lateral flow assays market in 2021”
The North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2021, Asia-Pacific accounted for the second largest share of the lateral flow assays market, followed by Europe, Latin America, and the Middle East & Africa. However, the North America is a leading region in the lateral flow assay market. Being a high-growth market, many manufacturers are also extending their manufacturing bases in the Asia Pacific, which boasts low-cost manufacturing advantages and the availability of a skilled workforce, especially in China and India. These countries are also regarded as the most profitable manufacturing and R&D locations across the globe. The key factors hindering market growth in this region are a lack of awareness about the advantages of near-patient testing products due to low literacy rates, lack of reimbursements, challenges related to locational remoteness, and the reluctance of physicians to change existing practices.

A breakdown of the primary participants (supply-side) for the lateral flow assays market referred to for this report is provided below:
• By Company Type: Tier 1–35%, Tier 2–20%, and Tier 3–45%
• By Designation: C-level–45%, Director Level–25%, and Others–30%
• By Region: North America–36%, Europe–26%, Asia Pacific–21%, Latin America- 10%, and Middle East and Africa– 7%
Some of the key players in the Lateral flow assays market are Abbott Laboratories (US), F. Hoffman-La Roche AG (Switzerland), Danaher Corporation (US), Siemens AG (Germany), BD (US), bioMérieux SA (France), Thermo Fisher Scientific, Inc. (US), PerkinElmer Inc. (US), Hologic Inc. (US), QIAGEN N.V. (Netherlands), Quidel Corporation (US), and Merck KGaA (Germany).

Research Coverage:
The market study covers the lateral flow assays market across various segments. It aims at estimating the market size and the growth potential of this market across different segments by product type, application by technique, by sample type, end user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants in this market and provide information regarding the closest approximations of the lateral flow assays market and its segments. This report will help stakeholders understand the competitive landscape, gain insights to position their businesses better, and plan suitable go-to-market strategies. The report will also help stakeholders in understanding the pulse of the market and gaining information on key market drivers, restraints, opportunities, and challenges.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療機器）の最新刊レポート

MarketsandMarkets社のMedical Devices分野での最新刊レポート

本レポートと同じKEY WORD（assays）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（医療機器）の最新刊レポート

MarketsandMarkets社のMedical Devices分野での最新刊レポート

本レポートと同じKEY WORD（assays）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?